Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is increasingly offered as an acceptable and economic alternative to insulin for treatment of gestational diabetes mellitus (GDM) in many countries. However, the impact of maternal metformin treatment on the trajectory of fetal, infant, and childhood growth is unknown. METHODS AND FINDINGS: PubMed, Ovid Embase, Medline, Web of Science, ClinicalTrials.gov, and the Cochrane database were systematically searched (from database inception to 26 February 2019). Outcomes of GDM-affected pregnancies randomised to treatment with metformin versus insulin were included (randomised controlled trials and prospective randomised controlled studies) from cohorts including European, American, Asian, Australian, and African women. Studies including pregnant women with pre-existing diabetes or non-diabetic women were excluded, as were trials comparing metformin treatment with oral glucose-lowering agents other than insulin. Two reviewers independently assessed articles for eligibility and risk of bias, and conflicts were resolved by a third reviewer. Outcome measures were parameters of fetal, infant, and childhood growth, including weight, height, BMI, and body composition. In total, 28 studies (n = 3,976 participants) met eligibility criteria and were included in the meta-analysis. No studies reported fetal growth parameters; 19 studies (n = 3,723 neonates) reported measures of neonatal growth. Neonates born to metformin-treated mothers had lower birth weights (mean difference -107.7 g, 95% CI -182.3 to -32.7, I2 = 83%, p = 0.005) and lower ponderal indices (mean difference -0.13 kg/m3, 95% CI -0.26 to 0.00, I2 = 0%, p = 0.04) than neonates of insulin-treated mothers. The odds of macrosomia (odds ratio [OR] 0.59, 95% CI 0.46 to 0.77, p < 0.001) and large for gestational age (OR 0.78, 95% CI 0.62 to 0.99, p = 0.04) were lower following maternal treatment with metformin compared to insulin. There was no difference in neonatal height or incidence of small for gestational age between groups. Two studies (n = 411 infants) reported measures of infant growth (18-24 months of age). In contrast to the neonatal phase, metformin-exposed infants were significantly heavier than those in the insulin-exposed group (mean difference 440 g, 95% CI 50 to 830, I2 = 4%, p = 0.03). Three studies (n = 520 children) reported mid-childhood growth parameters (5-9 years). In mid-childhood, BMI was significantly higher (mean difference 0.78 kg/m2, 95% CI 0.23 to 1.33, I2 = 7%, p = 0.005) following metformin exposure than following insulin exposure, although the difference in absolute weights between the groups was not significantly different (p = 0.09). Limited evidence (1 study with data treated as 2 cohorts) suggested that adiposity indices (abdominal [p = 0.02] and visceral [p = 0.03] fat volumes) may be higher in children born to metformin-treated compared to insulin-treated mothers. Study limitations include heterogeneity in metformin dosing, heterogeneity in diagnostic criteria for GDM, and the scarcity of reporting of childhood outcomes. CONCLUSIONS: Following intrauterine exposure to metformin for treatment of maternal GDM, neonates are significantly smaller than neonates whose mothers were treated with insulin during pregnancy. Despite lower average birth weight, metformin-exposed children appear to experience accelerated postnatal growth, resulting in heavier infants and higher BMI by mid-childhood compared to children whose mothers were treated with insulin. Such patterns of low birth weight and postnatal catch-up growth have been reported to be associated with adverse long-term cardio-metabolic outcomes. This suggests a need for further studies examining longitudinal perinatal and childhood outcomes following intrauterine metformin exposure. This review protocol was registered with PROSPERO under registration number CRD42018117503.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A follow-up study at 5-10 years showed that the offspring had higher BMI, weight-toheight ratios, waist circumferences, and a borderline increase in fat mass (88,89).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A meta-analysis demonstrated that metformin exposure resulted in smaller neonates with an acceleration of postnatal growth, resulting in higher BMI in childhood (88).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,500
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Association between postnatal catch-up growth and obesity in childhood: prospective cohort study
Ong, K. K. L. (2000) · BMJ · doi:10.1136/bmj.320.7240.967 · Cited by 1,668
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
Catch-up growth in childhood and death from coronary heart disease: longitudinal study
Eriksson, J. G., Forsen, T., Tuomilehto, J., Winter, P. D., Osmond, C., & Barker, D. J. P. (1999) · BMJ · doi:10.1136/bmj.318.7181.427 · Cited by 1,148
Gestational Diabetes Mellitus and Macrosomia: A Literature Review
KC, K., Shakya, S., & Zhang, H. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000371628 · Cited by 917
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
The Fetal and Childhood Growth of Persons Who Develop Type 2 Diabetes
Forsén, T., Eriksson, J., Tuomilehto, J., Reunanen, A., Osmond, C., & Barker, D. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-3-200008010-00008 · Cited by 721
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30007-2 · Cited by 558
Forsen, T., Eriksson, J. G., Tuomilehto, J., Osmond, C., & Barker, D. J. P. (1999) · BMJ · doi:10.1136/bmj.319.7222.1403 · Cited by 481
Law, C. M., Shiell, A. W., Newsome, C. A., Syddall, H. E., Shinebourne, E. A., Fayers, P. M., Martyn, C. N., & de Swiet, M. (2002) · Circulation · doi:10.1161/hc0902.104677 · Cited by 468
Howell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia
Combs, C. A., Singh, N. B., & Khoury, J. C. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90050-7 · Cited by 376
Gestational diabetes: A clinical update
Kampmann, U. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1065 · Cited by 325
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Jansson, N., Rosario, F. J., Gaccioli, F., Lager, S., Jones, H. N., Roos, S., Jansson, T., & Powell, T. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2667 · Cited by 305
Chiswick, C., Reynolds, R. M., Denison, F., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S., Wray, S., Weeks, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00219-3 · Cited by 260
Long-Term Adverse Effects of Early Growth Acceleration or Catch-Up Growth
Singhal, A. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000464302 · Cited by 240
Crowther, N. J., Cameron, N., Trusler, J., & Gray, I. P. (1998) · Diabetologia · doi:10.1007/s001250051046 · Cited by 239
Sovio, U., Murphy, H. R., & Smith, G. C. S. (2016) · Diabetes Care · doi:10.2337/dc16-0160 · Cited by 220
Rich-Edwards, J. W., Kleinman, K., Michels, K. B., Stampfer, M. J., Manson, J. E., Rexrode, K. M., Hibert, E. N., & Willett, W. C. (2005) · BMJ · doi:10.1136/bmj.38434.629630.e0 · Cited by 219
Rapid Child Growth Raises Blood Pressure in Adolescent Boys Who Were Thin at Birth
Adair, L. S., & Cole, T. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000054212.23528.b2 · Cited by 218
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Population pharmacokinetics of metformin in late pregnancy
Charles, B., Norris, R., Xiao, X., & Hague, W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000184161.52573.0e · Cited by 212
Pharmacokinetics of metformin during pregnancy
Eyal, S., Easterling, T. R., Carr, D., Umans, J. G., Miodovnik, M., Hankins, G. D. V., Clark, S. M., Risler, L., Wang, J., Kelly, E. J., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031245 · Cited by 209
Maternal and neonatal outcomes of large for gestational age pregnancies
WEISSMANN‐BRENNER, A., SIMCHEN, M. J., ZILBERBERG, E., KALTER, A., WEISZ, B., ACHIRON, R., & DULITZKY, M. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01412.x · Cited by 204
Niromanesh, S., Alavi, A., Sharbaf, F. R., Amjadi, N., Moosavi, S., & Akbari, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.031 · Cited by 203
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
The costs of diabetes treatment in low- and middle-income countries: a systematic review
Moucheraud, C., Lenz, C., Latkovic, M., & Wirtz, V. J. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001258 · Cited by 198
The Prevalence of Gestational Diabetes
Melchior, H., Kurch-Bek, D., & Mund, M. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0412 · Cited by 185
Randomized trial of metformin vs insulin in the management of gestational diabetes
Spaulonci, C. P., Bernardes, L. S., Trindade, T. C., Zugaib, M., & Francisco, R. P. V. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.022 · Cited by 183
Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T., & Rönnemaa, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12017 · Cited by 174
Hanem, L. G. E., Salvesen, Ø., Juliusson, P. B., Carlsen, S. M., Nossum, M. C. F., Vaage, M. Ø., Ødegård, R., & Vanky, E. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30385-7 · Cited by 134
Ijäs, H., Vääräsmäki, M., Saarela, T., Keravuo, R., & Raudaskoski, T. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12964 · Cited by 127
Metformin use in pregnancy: promises and uncertainties
Lindsay, R. S., & Loeken, M. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4351-y · Cited by 127
Prenatal origins of adult disease
Nijland, M. J., Ford, S. P., & Nathanielsz, P. W. (2008) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/gco.0b013e3282f76753 · Cited by 126
Moore, L. E., Briery, C. M., Clokey, D., Martin, R. W., Williford, N. J., Bofill, J. A., & Morrison, J. C. (2007) · PubMed · Cited by 123
Ainuddin, J., Karim, N., Hasan, A. A., & Naqvi, S. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.001 · Cited by 119
Mesdaghinia, E., Samimi, M., Homaei, Z., Saberi, F., Moosavi, S. G. A., & Yaribakht, M. (2013) · PubMed Central · Cited by 107
Metformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 101
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
SMFM statement: pharmacological treatment of gestational diabetes
(2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.041 · Cited by 94
A review of current treatment strategies for gestational diabetes mellitus
Kelley, K., Carroll, D., & Meyer, A. (2015) · Drugs in Context · doi:10.7573/dic.212282 · Cited by 88
Ashoush, S., El‐Said, M., Fathi, H., & Abdelnaby, M. (2016) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12950 · Cited by 80
Ghomian, N., Vahed, S. H. M., Firouz, S., Yaghoubi, M. A., Mohebbi, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27238 · Cited by 77
Lee, N., Hébert, M. F., Prasad, B., Easterling, T. R., Kelly, E. J., Unadkat, J. D., & Wang, J. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054072 · Cited by 73
Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety
Nicholson, W., & Baptiste-Roberts, K. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.018 · Cited by 72
Sridhar, S. B., Ferrara, A., Ehrlich, S. F., Brown, S. D., & Hedderson, M. M. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318291b15c · Cited by 66
Diabetes during Pregnancy in Low- and Middle-Income Countries
McClure, E., Harrison, M., Miodovnik, M., & Goldenberg, R. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1584152 · Cited by 63
Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
Saleh, H. S., Abdelsalam, W. A., Mowafy, H. E., & Abd ElHameid, A. A. (2016) · International Journal of Reproductive Medicine · doi:10.1155/2016/3480629 · Cited by 61
Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis
Goetzl, L., & Wilkins, I. (2002) · Journal of Perinatology · doi:10.1038/sj.jp.7210759 · Cited by 54
Hu, G., Bouchard, C., Bray, G. A., Greenway, F. L., Johnson, W. D., Newton, R. L., Ravussin, E., Ryan, D. H., & Katzmarzyk, P. T. (2011) · Diabetes Care · doi:10.2337/dc10-2019 · Cited by 54
van Weelden, W., Wekker, V., de Wit, L., Limpens, J., Ijäs, H., van Wassenaer-Leemhuis, A. G., Roseboom, T. J., van Rijn, B. B., DeVries, J. H., & Painter, R. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0479-0 · Cited by 51
The UK Prospective Diabetes study
Bailey, C. J., & Grant, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)00090-7 · Cited by 49
Ruholamin, S., Eshaghian, S., & Allame, Z. (2014) · PubMed Central · Cited by 46
Tertti, K., Eskola, E., Rönnemaa, T., & Haataja, L. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000230 · Cited by 44
Metformin prevents macrosomia and neonatal morbidity in gestational diabetes
Hasan, J. A., Karim, N., & Sheikh, Z. (2012) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.283.1686 · Cited by 39
Feto-maternal outcomes and Glycemic control in Metforminversus insulin treated Gestational Diabetics
Arshad, R., Khanam, S., SHAIKH, D. F., & Karim, D. N. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.335.13286 · Cited by 37
Tertti, K., Toppari, J., Virtanen, H. E., Sadov, S., & Rönnemaa, T. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.59 · Cited by 36
Neonatal outcomes of macrosomic infants of diabetic and non-diabetic mothers
Cordero, L., Paetow, P., Landon, M. B., & Nankervis, C. A. (2015) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-15814102 · Cited by 35
Tertti, K., Laine, K., Ekblad, U., Rinne, V. M., & Rönnemaa, T. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0570-6 · Cited by 35
Oral Agents for the Treatment of Gestational Diabetes
Finneran, M. M., & Landon, M. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1093-2 · Cited by 34
Eid, S. R., Moustafa, R. S. I., Salah, M. M., Hanafy, S. K., Aly, R. H., Mostafa, W. G., & Ghanem, A. I. M. (2018) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2018.01.002 · Cited by 24
Chiswick, C. A., Reynolds, R. M., Denison, F. C., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S. M., Wray, S., Weeks, A. D., et al. (2016) · Efficacy and Mechanism Evaluation · doi:10.3310/eme03070 · Cited by 11
TREATMENT OF GESTATIONAL DIABETES MELLITUS: INSULIN OR METFORMIN?
Somani, P. S., Sahana, P. K., Chaudhuri, P., & Sengupta, N. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/1011 · Cited by 10
Metformin Opposed to Insulin in the Management of Gestational Diabetes
Borg, H. M., & Ezat, S. (2016) · Cited by 9
Comparison of Metformin with Insulin in the Management of Gestational Diabetes
Bukhari, S. M., Awan, M., & Ayoub, I. (2019) · Journal of Medicine, Physiology and Biophysics · doi:10.7176/jmpb/54-11 · Cited by 9
Rowan, J., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000547170.99000.49 · Cited by 7
Could there be a role for metformin in type 1 and type 2 diabetic pregnancies?
Pernicova, I., Prasai, M. J., Close, E. J., Drury, K., Gilbey, S. G., Brewster, J. A., & SCOTT, E. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2256-8 · Cited by 5
Rowan, J. A., Rush, E. C., Plank Lindsay, D., Lu, J., Obolonkin, V., Coat, S., Hague, W. M., 张贝, & 巩纯秀 (2018) · doi:10.3760/cma.j.issn.1007-9742.2018.09.120 · Cited by 2
Research works printed but not linked: 2
- Hamadani A, Zahid S, Butt ZB. Metformin versus insulin treatment in gestational diabetes in pregnancy and their effects on neonatal birthweight. Pak J Med Sci. 2017; 11: 914– 6.
- International Diabetes Federation. IDF diabetes atlas— 8th edition Brussels: International Diabetes Federation; 2017.
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062965 · Cited by 339
“8 kg/m2) at 5–9 years of age than those of mothers who received insulin [162].”
BackgroundMethod
Metadata
- Authors
- Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E.
- Affiliations
- University of Cambridge (GB)
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-08-06
- Volume
- 16
- Issue
- 8
- Pages
- e1002848
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6684046
- OpenAlex
- W2963238421
- Cited by
- 251
- References
- 77
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 37 · 2023: 59 · 2022: 35 · 2021: 41 · 2020: 23 · 2019: 3
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Apollo
- Funders
- British Heart Foundation (RG/17/12/33167)
- Medical Research Council (MC_ UU_12012/4)
- Addenbrooke's Charitable Trust, Cambridge University Hospitals (GB)
- Isaac Newton Trust
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, metformin, insulin therapy, neonatal growth, infant growth, child growth, birth weight, macrosomia, large for gestational age, small for gestational age, body composition, fetal growth, childhood obesity risk, child height, child weight gain, childhood adiposity
- MeSH terms
- Child Development, Child, Preschool, Female, Humans, Hypoglycemic Agents, Infant, Infant, Newborn, Insulin, Metformin, Pregnancy, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.